Systems modeling of white matter microstructural abnormalities in Alzheimer's disease

dc.contributor.authorHorgusluoglu-Moloch, Emrin
dc.contributor.authorXiao, Gaoyu
dc.contributor.authorWang, Minghui
dc.contributor.authorWang, Qian
dc.contributor.authorZhou, Xianxiao
dc.contributor.authorNho, Kwangsik
dc.contributor.authorSaykin, Andrew J.
dc.contributor.authorSchadt, Eric
dc.contributor.authorZhang, Bin
dc.contributor.authorAlzheimer's Disease Neuroimaging Initiative (ADNI)
dc.contributor.departmentRadiology and Imaging Sciences, School of Medicineen_US
dc.date.accessioned2020-03-31T12:30:11Z
dc.date.available2020-03-31T12:30:11Z
dc.date.issued2020-02-04
dc.description.abstractINTRODUCTION: Microstructural abnormalities in white matter (WM) are often reported in Alzheimer's disease (AD). However, it is unclear which brain regions have the strongest WM changes in presymptomatic AD and what biological processes underlie WM abnormality during disease progression. METHODS: We developed a systems biology framework to integrate matched diffusion tensor imaging (DTI), genetic and transcriptomic data to investigate regional vulnerability to AD and identify genetic risk factors and gene subnetworks underlying WM abnormality in AD. RESULTS: We quantified regional WM abnormality and identified most vulnerable brain regions. A SNP rs2203712 in CELF1 was most significantly associated with several DTI-derived features in the hippocampus, the top ranked brain region. An immune response gene subnetwork in the blood was most correlated with DTI features across all the brain regions. DISCUSSION: Incorporation of image analysis with gene network analysis enhances our understanding of disease progression and facilitates identification of novel therapeutic strategies for AD.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationHorgusluoglu-Moloch, E., Xiao, G., Wang, M., Wang, Q., Zhou, X., Nho, K., Saykin, A. J., Schadt, E., Zhang, B., & Alzheimer's Disease Neuroimaging Initiative (ADNI) (2020). Systems modeling of white matter microstructural abnormalities in Alzheimer's disease. NeuroImage. Clinical, 26, 102203. Advance online publication. https://doi.org/10.1016/j.nicl.2020.102203en_US
dc.identifier.urihttps://hdl.handle.net/1805/22432
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.nicl.2020.102203en_US
dc.relation.journalNeuroImage Clinicalen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePMCen_US
dc.subjectAlzheimer's diseaseen_US
dc.subjectBrain regionsen_US
dc.subjectCELF1en_US
dc.subjectDiffusion tensor imagingen_US
dc.subjectGene expressionen_US
dc.subjectImmune responseen_US
dc.subjectMultiscale embedded gene coexpression network analysisen_US
dc.subjectWhite matteren_US
dc.titleSystems modeling of white matter microstructural abnormalities in Alzheimer's diseaseen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
main.pdf
Size:
3.29 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: